Measurement of serum calprotectin in stable patients predicts exacerbation and lung function decline in cystic fibrosis

Am J Respir Crit Care Med. 2015 Jan 15;191(2):233-6. doi: 10.1164/rccm.201407-1365LE.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / blood
  • Cystic Fibrosis / blood*
  • Disease Progression*
  • Forced Expiratory Volume
  • Humans
  • Leukocyte L1 Antigen Complex / blood*
  • Lung / physiopathology*
  • Male
  • Prognosis
  • Proportional Hazards Models
  • Prospective Studies
  • Time Factors
  • Vital Capacity

Substances

  • Biomarkers
  • Leukocyte L1 Antigen Complex